Please login to the form below

Not currently logged in
Email:
Password:

NeuroVive

This page shows the latest NeuroVive news and features for those working in and with pharma, biotech and healthcare.

Sanofi licenses cardiovascular therapy in South Korea

Sanofi licenses cardiovascular therapy in South Korea

Phase III drug comes from Swedish company NeuroVive.  . Sanofi has licensed an experimental drug from Swedish company NeuroVive that bolsters its cardiovascular therapy pipeline. . ... NeuroVive's chief executive Mikael Brönnegård said the deal with

Latest news

  • inVentiv extends collaboration with NeuroVive inVentiv extends collaboration with NeuroVive

    The partnership builds on a one-year regulatory consulting collaboration between NeuroVive and ParagonRx, inVentiv's risk mitigation service. ... NeuroVive and inVentiv are already discussing a broader expansion of the partnership to include future

  • Collaboration on stroke therapy

    NeuroVive Pharmaceutical and to-BBB are to work together to develop therapies for stroke and other acute neurodegenerative diseases. ... brain barrier (BBB) to significantly prevent drug penetration to the central nervous system (CNS)," said Dr Eskil

  • Brain injury drug granted orphan status

    The European Commission has granted orphan drug designation to NeuroVive's NeuroSTAT for moderate to severe traumatic brain injury. ... patents for cyclosporine neuroprotection against chronic neurological diseases, remains NeuroVive's largest single

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch table for September 2014 Deal Watch table for September 2014

    153. NeuroVive / OnCore. Licence and collaboration. NVP018 an oral sangamide-based 2nd generation cyclophilin inhibitor for hepatitis B.

  • Pharma deals during November 2012 Pharma deals during November 2012

    8. Sihuan Pharmaceutical / NeuroVive Pharmaceutical. Collaboration agreement. CicloMulsion / NeuroSTAT to treat heart reperfusion / traumatic brain injuries. ... Canadian research facility.  South Korea market.  Pursuant to the collaboration agreement,

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • NeuroVive appoints new chief executive officer NeuroVive appoints new chief executive officer

    The combination of his strategic vision and medical expertise is an excellent fit with NeuroVive's strategy refocused towards R&D.”. ... Kinnman said: “I am excited about NeuroVive, the CEO role, and the opportunity to contribute to the success and

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics